REFERENCES
- Shah V. P., Yamamoto L. A., Shuirmann D., Elkins J., Skelly J. P. Pharm. Res. 1987; 4: 416
- Chow S. C., Ki F. Y. C. J. Biopharm. Stat. 1997; 7: 241
- Sather P., Tsong Y., Shah V. P. Pharm. Res. 1996; 13: 1799
- Tsong T., Hammerstrom T., Sathe P., Shah V. P. Drug Inf. J. 1996; 30: 1105
- Moore J. W., Flanner H. H. Pharm. Tech. 1996; 20(6)64
- Food and Drug Administration. FDA Guidance for Industry: Immediate Release Solid Dosage Forms: Scale-up and Post Approval Changes (SUPAC-IR): Chemistry, Manufacturing and Controls. Author, Rockville, MD November 1995, In vitro dissolution testing and in vivo bioequivalence documentation
- Food and Drug Administration. FDA Guidance for Industry: Dissolution Testing of Immediate Release Solid Oral Dosage Forms. Author, Rockville, MD August 1997
- Food and Drug Administration. FDA Guidance for Industry: Extended Release Oral Dosage Forms: Development, Evaluation and Application of In Vitro/In Vivo Correlation. Author, Rockville, MD September 1997
- Food and Drug Administration. FDA Guidance for Industry: Modified Release Solid Oral Dosage Forms: Scale-up and Post Approval Changes (SUPAC-MR): Chemistry, Manufacturing and Controls. Author, Rockville, MD September 1997, In vitro dissolution testing and in vivo bioequivalence documentation
- Polli J. E., Rekhi G. S., Shah V. P. Drug Info. J. 1996; 30: 1113
- Polli J. E., Rekhi G. S., Augsburger L. L., Shah V. P. J. Pharm. Sci. 1997; 86: 690
- Liu J. P., Ma M. C., Chow S. C. Drug Inf. J. 1997; 31: 1255
- Ju H. L., Liaw S. Drug Inf. J. 1997; 31: 1273
- Shah V. P., Tsong Y., Sathe P., Liu J. P. Pharm. Res. 1998; 15(6)889
- Tapia C., Buckton G., Newton J. M. Int. J. Pharm. 1993; 92: 211